Calls
1
u/JRshoe1997
Reddit r/stocks
Win Rate
100.0%
return
+4.4%
Loading charts...
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Apr 20
$96.43
+4.4%
ABT trades at a 16x EV/EBITDA multiple, its cheapest in years, while being a "Dividend King" with a healthy balance sheet and dominant, recession-resistant segments (Medical Devices, Pharmaceuticals). The market is overly punishing the stock for short-term issues (consumer pushback in Nutrition, post-pandemic Diagnostics decline), creating a valuation gap for a stable, growing company. ABT is a high-quality stock that is a buy for long-term value and dividend growth investors. Ongoing baby formula lawsuits harming the Nutrition segment, and the large acquisition/ integration of Exact Sciences failing to stabilize the Diagnostics segment.
ABT trades at a 16x EV/EBITDA multiple, its cheapest in years, while being a "Dividend King" with a healthy balance sheet and dominant, recession-resistant segments (Medical Devices, Pharmaceuticals). The market is overly punishing the stock for short-term issues (consumer pushback in Nutrition, post-pandemic Diagnostics decline), creating a valuation gap for a stable, growing company. ABT is a high-quality stock that is a buy for long-term value and dividend growth investors. Ongoing baby formula lawsuits harming the Nutrition segment, and the large acquisition/ integration of Exact Sciences failing to stabilize the Diagnostics segment.
MedTech
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/JRshoe1997 has 1 trade ideas tracked on Buzzberg across 1 tickers since April 2026. Most covered: ABT.
